Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models
/PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced two...
Source: prnewswire.com